Asklepios MVZ Bayern GmbH — Clinical Trial Site

8 Registered trials

3 Currently recruiting

Organisation

Asklepios MVZ Bayern GmbH

Location

Landsberg Am Lech, Germany

Identifier

ORG-100047647

Address

Bahnhofsplatz 2, 86899, Germany

Departments

Asklepios MVZ Bayern GmbH
N/A
NA
Pneumologie

Clinical trials at this site (8)

Search interface

A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease Recruiting

2025-520473-40-00 Moderate to Very Severe Chronic Obstructive Pulmonary D 4 2025-09-29
A trial to learn how well benralizumab works and how safe it is when given in addition to standard asthma treatments in people with eosinoph… Recruiting

2024-515162-13-00 Eosinophilic Asthma 5 2025-04-29
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
A trial to learn how safe AZD8630 is and how well it works in adults with uncontrolled asthma. Ended

2024-514228-18-00 Asthma in adults who remain uncontrolled despite medium 4 2025-01-16
Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler in Patients with Inadequately Controlled Asthma Ended

2024-513568-24-00 Inadequately Controlled Asthma 5 2022-03-23
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-507093-40-00 Chronic Obstructive Pulmonary Disease (COPD) 4 2022-01-27
Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin… Ended

2023-510230-84-00 Severe asthma with an eosinophilic phenotype 5 2021-05-28
A Variable Length Study to Evaluate the Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol inhaler in Adults and Adolescents with S… Ended

2023-505786-88-00 Severe and inadequately controlled asthma 5 2021-04-25